• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Brickell Biotech, Inc. - Common Stock (NQ: BBI )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Sep 7, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Brickell Biotech, Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers DBV Technologies (NASDAQ:DBVT) sh... 
    Via Benzinga
    Stocks Swimming in Red Ink as Earnings, Yields Weigh
    The Dow Jones Industrial Average is down a brutal 481 points at midday, extending this morning's losses. The S&P 500 and Nasdaq are swimming in red ink as well, as the 10-year Treasury yield climbs to... 
    Via Talk Markets
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 71.1% to $0.36 during Tuesday's regular session. Brickell Biotech's stock is trading at a volume of... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Brickell Biotech (NASDAQ:BBI) shares rose 37.0% to $0.28 during Tuesday's pre-market session. The market value of their outstanding shares is at $32.7 million... 
    Via Benzinga
    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
    Via Benzinga
    Exposures Product Safety
    Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
    Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE: 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    I hope you enjoyed the long weekend, but it's time to get back into investing with the biggest pre-market stock movers for Tuesday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers GBS (NASDAQ:GBS 
    Via Benzinga
    22 Stocks Moving in Wednesday's Pre-Market Session
    Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment... 
    Via Benzinga
    Exposures Product Safety
    Brickell Biotech's Return On Capital Employed Insights
    Benzinga Pro data, Brickell Biotech (NASDAQ:BBI) reported Q2 sales of $151.00 thousand. Earnings fell to a loss of $11.58 million, resulting in a 28.62% decrease from last... 
    Via Benzinga
    66 Biggest Movers From Yesterday
    Gainers HCW Biologics Inc. (NASDAQ: HCWB) shares surged 62% to close at $4.73 on Thursday after the company announced that it has been cleared by the U.S. Food and Drug... 
    Via Benzinga
    Mid-Afternoon Market Update: Dow Surges 160 Points; Wolfspeed Shares Gain After Q1 Results
    Toward the end of trading Thursday, the Dow traded up 0.45% to 35,651.09 while the NASDAQ rose 1.21% to 15,420.51. The S&P also rose, gaining 0.83% to 4,589.40. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers Kiromic BioPharma (NASDAQ:KRBP) stock moved upwards by 21.62% to $2.25 during Thursday's regular session. Trading volume for Kiromic BioPharma's stock is... 
    Via Benzinga
    Mid-Day Market Update: Nasdaq Rises Over 1%; Rafael Holdings Shares Slide
    Midway through trading Thursday, the Dow traded up 0.40% to 35,631.75 while the NASDAQ rose 1.09% to 15,401.19. The S&P also rose, gaining 0.74% to 4,585.17. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Medigus (NASDAQ:MDGS) shares moved upwards by 12.04% to $1.62 during Thursday's pre-market session. The market value of their outstanding shares is at $38.6... 
    Via Benzinga
    The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
    Via Benzinga
    30 Stocks Moving in Thursday's Pre-Market Session
    Gainers InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target.... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Galera Therapeutics (NASDAQ:GRTX... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock... 
    Via Benzinga
    Brickell Biotech Aces Pivotal Sofpironium Trials In Patients With Excessive Underarm Sweating
    Brickell Biotech Inc (NASDAQ: BBI) has announced positive topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies of sofpironium bromide gel... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 20.46% to $0.8 during Thursday's pre-market session. The company's market cap stands at $68.5 million... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    Looking Into Brickell Biotech's Return On Capital Employed
    Brickell Biotech (NASDAQ:BBI) brought in sales totaling $151.00 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 28.62%, resulting in a... 
    Via Benzinga
    Brickell Biotech Acquires Rights To Candidate For Autoimmune Diseases
    Brickell Biotech Inc (NASDAQ: BBI) has entered into a definitive agreement with Voronoi Inc for exclusive, worldwide rights to therapeutics generated from a proprietary DYRK1A... 
    Via Benzinga
    The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
    Via Benzinga
    The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers NanoVibronix (NASDAQ:NAOV) share... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Second Sight Medical (NASDAQ:EYES 
    Via Benzinga
    62 Biggest Movers From Yesterday
    Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
    Via Benzinga
    Exposures Product Safety
    Why Brickell Biotech Shares Are Trading Lower Today
    Brickell Biotech (NASDAQ: BBI) shares are trading lower after the company announced a bought deal offering of common stock of $5 million, which was later increased to $7 million.... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.